Stijn L.W. Koolen

Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001)

Johannes J. Moes, Stijn L.W. Koolen, Alwin D. R. Huitema et al. · International Journal of Pharmaceutics · 2011 · 104 citations

Pharmacy, Pharmaceutics, Pharmacology +10

Overt Thyroid Dysfunction and Anti-Thyroid Antibodies Predict Response to Anti-PD-1 Immunotherapy in Cancer Patients

Edwin A. Basak, Jan W.M. van der Meer, Daan P. Hurkmans et al. · Thyroid · 2020 · 88 citations

Life Sciences, Immunology, Oncology +17

A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients

Daan P. Hurkmans, Edwin A. Basak, Tanja C. van Dijk et al. · Journal for ImmunoTherapy of Cancer · 2019 · 82 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Therapeutic drug monitoring-based precision dosing of oral targeted therapies in oncology: a prospective multicenter study

Stefanie L. Groenland, Ruben A.G. van Eerden, Kim Westerdijk et al. · Annals of Oncology · 2022 · 75 citations · Full text

Medicine, Oncology, Pharmacology +16

Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel

Johannes J. Moes, Stijn L.W. Koolen, Alwin D. R. Huitema et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2012 · 73 citations

Pharmacy, Pharmaceutics, Pharmacology +14